Search jobs 28-Apr-2021 Toxys and Unilever Enter Agreement to Further Validate and Expand ReproTracker® for Animal-Free Developmental Toxicity Assessment
Toxys and Unilever Enter Agreement to Further Validate and Expand ReproTracker® for Animal-Free Developmental Toxicity Assessment
Toxys and Unilever will start a collaborative R&D project to further validate and develop the ReproTracker assay, a human cell assay for in vitro teratogenicity testing.
LEIDEN, The Netherlands and BEDFORD, UK, April 28, 2021 / / Toxys and Unilever Safety and Environmental Assurance Centre (SEAC) have entered into an agreement to further validate and expand the ReproTracker assay.
Testing for developmental toxicity according to the current international guidelines requires large numbers of animals, making these tests very resource-intensive and time-consuming as well as raising ethical concerns. The current ReproTracker
Consortium led by TU Eindhoven wins €4 8M grant to develop organ-on-chips , small chips with human cells | Science
sciencebusiness.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencebusiness.net Daily Mail and Mail on Sunday newspapers.
Organ-on-a-chip project receives huge grant to make leap from lab to fab
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Organ-on-chip consortium receives huge grant to develop a universal standard for pharmaceutical industry
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.